79% of Young Adults Show Signs of Cardiovascular, Kidney, Metabolic Issues
Recent research shows that around 79% of young adults show signs of CKM. pixelfit · E+/Getty A recent study has found that around 79% of adults in their 20s already show signs of cardiovascular-kidney-metabolic (CKM) syndrome.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Healthline; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories
Why it mattersRecent research shows that the shingles vaccine may help reduce the risk of cardiovascular disease. A boy and the sea · E+/Getty A recent study found that the recombinant shingles vaccine (Shingrix) was associated with a…
Recent research shows that the shingles vaccine may help reduce the risk of cardiovascular disease. A boy and the sea · E+/Getty A recent study found that the r…
By Chella·2h ago
Why it mattersThe FDA announced a recall of saline and other IV fluids over possible contamination with fiberglass, stainless steel, and other hazardous materials. RicardoImagen/E+/Getty Images Two companies recalled saline and other …
The FDA announced a recall of saline and other IV fluids over possible contamination with fiberglass, stainless steel, and other hazardous materials. RicardoIma…
By Chella·8h ago
Why it mattersMs. Foundation For Women 2016 Gloria Awards Gala & After Party.
Ms. Foundation For Women 2016 Gloria Awards Gala & After Party. NEW YORK, NY – APRIL 27: Journalist, social and political activist Gloria Steinem spea…
By Chella·19h ago
Why it mattersThe FDA approved Rasonque (daraxonrasib), a groundbreaking new drug to treat metastatic pancreatic cancer. Photo courtesy of Revolution Medicines The FDA approved Rasonque, a new drug to treat the most common type of pan…
The FDA approved Rasonque (daraxonrasib), a groundbreaking new drug to treat metastatic pancreatic cancer. Photo courtesy of Revolution Medicines The FDA approv…
By Chella·18h ago